4//SEC Filing
Hunt Nimrata 4
Accession 0000874716-25-000168
CIK 0000874716other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 5:01 PM ET
Size
18.3 KB
Accession
0000874716-25-000168
Insider Transaction Report
Form 4
Hunt Nimrata
Executive Vice President
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2025-11-07−7,125→ 0 totalExercise: $288.78Exp: 2030-02-13→ Common Stock (7,125 underlying) - Exercise/Conversion
Common Stock
2025-11-07$288.78/sh+7,125$2,057,557→ 25,168.944 total - Exercise/Conversion
Common Stock
2025-11-07$505.53/sh+5,405$2,732,390→ 30,573.944 total - Sale
Common Stock
2025-11-07$702.20/sh−5,114$3,591,059→ 25,459.944 total - Sale
Common Stock
2025-11-07$703.73/sh−1,465$1,030,970→ 23,994.944 total - Sale
Common Stock
2025-11-07$704.87/sh−1,468$1,034,743→ 22,526.944 total - Sale
Common Stock
2025-11-07$705.54/sh−1,378$972,241→ 21,148.944 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2025-11-07−5,405→ 1,604 totalExercise: $505.53Exp: 2032-02-13→ Common Stock (5,405 underlying)
Holdings
- 160(indirect: By Spouse)
Common Stock
Footnotes (7)
- [F1]Includes 11 shares purchased under the Issuer Employee Stock Purchase Plan on September 30, 2025.
- [F2]Represents the weighted average price of the shares sold ranging from a low of $702.00 to a high of $703.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F3]Represents the weighted average price of the shares sold ranging from a low of $703.05 to a high of $703.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F4]Represents the weighted average price of the shares sold ranging from a low of $704.235 to a high of $705.175 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F5]Represents the weighted average price of the shares sold ranging from a low of $705.26 to a high of $705.92 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- [F6]Grant of option to buy shares of Issuer common stock that vested in four annual installments beginning February 14, 2021.
- [F7]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001800619
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 5:01 PM ET
- Size
- 18.3 KB